Home/Filings/4/0001415889-23-005592
4//SEC Filing

Imran Talat 4

Accession 0001415889-23-005592

CIK 0001856725other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 8:59 PM ET

Size

7.3 KB

Accession

0001415889-23-005592

Insider Transaction Report

Form 4
Period: 2023-03-27
Imran Talat
DirectorChief Executive Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-27+353,500444,445 total
  • Award

    Stock Option (Right to Buy)

    2023-03-27+575,600575,600 total
    Exercise: $5.44Exp: 2033-03-26Class A Common Stock (575,600 underlying)
Footnotes (3)
  • [F1]The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
  • [F2]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F3]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001869579

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:59 PM ET
Size
7.3 KB